Search - tctmd.com

Displaying 41 - 60 of 378

Sort: Relevancy | Date

Presentation TCT 2020

TCT 163: Risk of Coronary Artery Bypass Graft in the 10 Years After Drug Eluting Stents

Presenter: Parth Parikh

October 14, 2020

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

Presenter: Lei Song

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation EuroPCR 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Presenter: Clemens von Birgelen

May 21, 2019

Presentation EuroPCR 2019

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Presenter: Raban Jeger

May 20, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation SIF 2019

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

Presenter: Douglas E. Drachman

March 27, 2019

Presentation JIM 2019

Unmet Clinical Needs With Current Drug-Eluting Stents

Presenter: Davide Capodanno

February 14, 2019

Presentation TCT 2018

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

Presenter: Jeroen J. Bax, Seung-Jung Park

September 24, 2018

Presentation TCT 2018

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

Presenter: Jeroen J. Bax, Daniel J.F.M. Thuijs

September 24, 2018

Presentation TCT 2018

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

Presenter: Fernando Alfonso, Juan F. Granada, Runlin Gao

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

Presentation TCT 2018

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Fernando Alfonso, Juan F. Granada, David E. Kandzari

September 23, 2018

Advertisement

TCT 163: Risk of Coronary Artery Bypass Graft in the 10 Years After Drug Eluting Stents

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Update: Drug-Eluting Stents

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

Unmet Clinical Needs With Current Drug-Eluting Stents

MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease

SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease (Preliminary Results)

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content